Herbert Tilg

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 72

Top Topics

Helicobacter Pylori

Cardiovascular Disease

Top Venues

Communications biology

Nature metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Heinz Zoller, Herbert Tilg
Ferritin-a promising biomarker in MASLD. Gut 73 (5) (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut (2024)
Timon Erik Adolph, Moritz Meyer, Almina Jukic, Herbert Tilg
Heavy arch: from inflammatory bowel diseases to metabolic disorders. Gut 73 (8) (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 73 (9) (2024)
Timon Erik Adolph, Herbert Tilg
Western diets and chronic diseases. Nature medicine (2024)
Timon Erik Adolph, Moritz Meyer, Almina Jukic, Herbert Tilg
Heavy arch: from inflammatory bowel diseases to metabolic disorders. Gut 73 (8) (2024)
Heinz Zoller, Herbert Tilg
Ferritin-a promising biomarker in MASLD. Gut 73 (5) (2024)
Timon Erik Adolph, Moritz Meyer, Almina Jukic, Herbert Tilg
Heavy arch: from inflammatory bowel diseases to metabolic disorders. Gut 73 (8) (2024)
Heinz Zoller, Herbert Tilg
Ferritin-a promising biomarker in MASLD. Gut 73 (5) (2024)
Heinz Zoller, Herbert Tilg
Ferritin-a promising biomarker in MASLD. Gut (2024)
Timon Erik Adolph, Herbert Tilg
Western diets and chronic diseases. Nature medicine 30 (8) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 73 (9) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Timon Erik Adolph, Herbert Tilg
Western diets and chronic diseases. Nature medicine 30 (8) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Timon Erik Adolph, Moritz Meyer, Almina Jukic, Herbert Tilg
Heavy arch: from inflammatory bowel diseases to metabolic disorders. Gut (2024)
Timon Erik Adolph, Moritz Meyer, Almina Jukic, Herbert Tilg
Heavy arch: from inflammatory bowel diseases to metabolic disorders. Gut 73 (8) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Heinz Zoller, Herbert Tilg
Ferritin-a promising biomarker in MASLD. Gut 73 (5) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Maria Effenberger, Silvio Waschina, Christina Bronowski, Gregor Sturm, Oronzo Tassiello, Felix Sommer, Andreas Zollner, Christina Watschinger, Felix Grabherr, Ronald Gstir, Christoph Grander, Barbara Enrich, Reto Bale, Daniel Putzer, Angela Djanani, Alexander R Moschen, Heinz Zoller, Jan Rupp, Stefan Schreiber, Remy Burcelin, Cornelia Lass-Flörl, Zlatko Trajanoski, Georg Oberhuber, Philip C Rosenstiel, Timon E Adolph, Konrad Aden, Herbert Tilg
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma. Hepatology communications 7 (7) (2023)
Loris Riccardo Lopetuso, Sara Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca G Ianiro, Luca Masucci, Maria Abreu, Iris Dotan, Samuel Paul Costello, Ailsa Hart, Tariq H Iqbal, Sudarshan Paramsothy, Maurizio Sanguinetti, Silvio Danese, Herbert Tilg, Fabio Cominelli, Theresa T Pizarro, Alessandro Armuzzi, Giovanni Cammarota, Antonio Gasbarrini, Severine Vermeire, Franco Scaldaferri
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut (2023)
Alessandro Mantovani, Herbert Tilg, Giovanni Targher
FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials. Gut (2023)
Maria Effenberger, Christoph Grander, Felix Grabherr, Herbert Tilg
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link. Journal of clinical and translational hepatology 11 (7) (2023)
Herbert Tilg, Heinz Zoller
Pleiotropic prebiotic for liver disease. Nature microbiology (2023)
Maria Effenberger, Christoph Grander, Felix Grabherr, Herbert Tilg
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link. Journal of clinical and translational hepatology 11 (7) (2023)
Julian Schwärzler, Andreas Zollner, Theresa Dolejsi, Lisa Mayr, Georg Oberhuber, Johannes Zschocke, Wolfgang Sturm, Ivan Tancevski, Timon Erik Adolph, Herbert Tilg
Inflammatory bowel disease in STAT1 gain-of-function immunodeficiency treated with precision medicine. Gut (2023)
Nikolai P Jaschke, Sophie Pählig, Anupam Sinha, Timon Erik Adolph, Maria Ledesma Colunga, Maura Hofmann, Andrew Wang, Sylvia Thiele, Julian Schwärzler, Alexander Kleymann, Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C Hofbauer, Martina Rauner, Andy Göbel, Tilman D Rachner
Dickkopf1 fuels inflammatory cytokine responses. Communications biology 5 (1) (2022)
Willem Meindert de Vos, Herbert Tilg, Matthias Van Hul, Patrice D Cani
Gut microbiome and health: mechanistic insights. Gut 71 (5) (2022)
Timon Erik Adolph, Moritz Meyer, Julian Schwärzler, Lisa Mayr, Felix Grabherr, Herbert Tilg
The metabolic nature of inflammatory bowel diseases. Nature reviews. Gastroenterology & hepatology 19 (12) (2022)
Jiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, Lindsey Decommer, Leen Rymenans, Sebastian Proost, Javier Centelles Lodeiro, Martin Weger, Marlene Notdurfter, Christoph Leitner, Peter Santer, Gregorio Rungger, Johann Willeit, Peter Willeit, Raimund Pechlaner, Felix Grabherr, Stefan Kiechl, Herbert Tilg, Jeroen Raes
Long-term life history predicts current gut microbiome in a population-based cohort study. Nature aging 2 (10) (2022)
Jean-François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg
COVID-19 and liver disease. Gut 71 (11) (2022)
Peter Malfertheiner, Francis Mégraud, Theodore Rokkas, Francisco Javier García-Alonso, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar, null null
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut (2022)
Marlene Panzer, André Viveiros, Benedikt Schaefer, Nadja Baumgartner, Klaus Seppi, Atbin Djamshidian, Theodor Todorov, William J H Griffiths, Eckart Schott, Markus Schuelke, Dennis Eurich, Albert Friedrich Stättermayer, Adrian Bomford, Pierre Foskett, Julia Vodopiutz, Katharina Staufer, Elke Pertler, Bernhard Morell, Herbert Tilg, Thomas Müller, Stefan Kiechl, Raul Jimenez Heredia, Karl Heinz Weiss, Si Houn Hahn, Andreas Janecke, Peter Ferenci, Heinz Zoller
Synonymous mutation in adenosine triphosphatase copper-transporting beta causes enhanced exon skipping in Wilson disease. Hepatology communications 6 (7) (2022)
Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Stefano Bonapace, Andrea Rossi, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals. Gut (2022)
Jiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, Lindsey Decommer, Leen Rymenans, Sebastian Proost, Javier Centelles Lodeiro, Martin Weger, Marlene Notdurfter, Christoph Leitner, Peter Santer, Gregorio Rungger, Johann Willeit, Peter Willeit, Raimund Pechlaner, Felix Grabherr, Stefan Kiechl, Herbert Tilg, Jeroen Raes
Long-term life history predicts current gut microbiome in a population-based cohort study. Nature aging 2 (10) (2022)
Alessandro Mantovani, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals. Gut (2022)
Nikolai P Jaschke, Sophie Pählig, Anupam Sinha, Timon Erik Adolph, Maria Ledesma Colunga, Maura Hofmann, Andrew Wang, Sylvia Thiele, Julian Schwärzler, Alexander Kleymann, Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C Hofbauer, Martina Rauner, Andy Göbel, Tilman D Rachner
Dickkopf1 fuels inflammatory cytokine responses. Communications biology 5 (1) (2022)
Julian Schwärzler, Lisa Mayr, Bernhard Radlinger, Felix Grabherr, Maureen Philipp, Bernhard Texler, Christoph Grander, Andreas Ritsch, Monika Hunjadi, Barbara Enrich, Karin Salzmann, Qitao Ran, Lukas A Huber, Herbert Tilg, Susanne Kaser, Timon Erik Adolph
Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation. International journal of obesity (2005) 46 (5) (2022)
Nikolai P Jaschke, Sophie Pählig, Anupam Sinha, Timon Erik Adolph, Maria Ledesma Colunga, Maura Hofmann, Andrew Wang, Sylvia Thiele, Julian Schwärzler, Alexander Kleymann, Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C Hofbauer, Martina Rauner, Andy Göbel, Tilman D Rachner
Dickkopf1 fuels inflammatory cytokine responses. Communications biology 5 (1) (2022)
Jiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, Lindsey Decommer, Leen Rymenans, Sebastian Proost, Javier Centelles Lodeiro, Martin Weger, Marlene Notdurfter, Christoph Leitner, Peter Santer, Gregorio Rungger, Johann Willeit, Peter Willeit, Raimund Pechlaner, Felix Grabherr, Stefan Kiechl, Herbert Tilg, Jeroen Raes
Long-term life history predicts current gut microbiome in a population-based cohort study. Nature aging 2 (10) (2022)
Nikolai P Jaschke, Sophie Pählig, Anupam Sinha, Timon Erik Adolph, Maria Ledesma Colunga, Maura Hofmann, Andrew Wang, Sylvia Thiele, Julian Schwärzler, Alexander Kleymann, Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C Hofbauer, Martina Rauner, Andy Göbel, Tilman D Rachner
Dickkopf1 fuels inflammatory cytokine responses. Communications biology 5 (1) (2022)
Nikolai P Jaschke, Sophie Pählig, Anupam Sinha, Timon Erik Adolph, Maria Ledesma Colunga, Maura Hofmann, Andrew Wang, Sylvia Thiele, Julian Schwärzler, Alexander Kleymann, Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C Hofbauer, Martina Rauner, Andy Göbel, Tilman D Rachner
Dickkopf1 fuels inflammatory cytokine responses. Communications biology 5 (1) (2022)
Maria Effenberger, Anissa A Widjaja, Felix Grabherr, Benedikt Schaefer, Christoph Grander, Lisa Mayr, Julian Schwaerzler, Barbara Enrich, Patrizia Moser, Julia Fink, Alisa Pedrini, Nikolai Jaschke, Alexander Kirchmair, Alexandra Pfister, Bela Hausmann, Reto Bale, Daniel Putzer, Heinz Zoller, Sebastian Schafer, Petra Pjevac, Zlatko Trajanoski, Georg Oberhuber, Timon Adolph, Stuart Cook, Herbert Tilg
Interleukin-11 drives human and mouse alcohol-related liver disease. Gut (2022)
Jiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, Lindsey Decommer, Leen Rymenans, Sebastian Proost, Javier Centelles Lodeiro, Martin Weger, Marlene Notdurfter, Christoph Leitner, Peter Santer, Gregorio Rungger, Johann Willeit, Peter Willeit, Raimund Pechlaner, Felix Grabherr, Stefan Kiechl, Herbert Tilg, Jeroen Raes
Long-term life history predicts current gut microbiome in a population-based cohort study. Nature aging 2 (10) (2022)
Jiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, Lindsey Decommer, Leen Rymenans, Sebastian Proost, Javier Centelles Lodeiro, Martin Weger, Marlene Notdurfter, Christoph Leitner, Peter Santer, Gregorio Rungger, Johann Willeit, Peter Willeit, Raimund Pechlaner, Felix Grabherr, Stefan Kiechl, Herbert Tilg, Jeroen Raes
Long-term life history predicts current gut microbiome in a population-based cohort study. Nature aging 2 (10) (2022)
Jean-François Dufour, Quentin Mark Anstee, Elisabetta Bugianesi, Stephen Harrison, Stephen Caldwell, Valerie Paradis, Herbert Tilg, Vincent Wai-Sun Wong, Shira Zelber-Sagi
Current therapies and new developments in NASH. Gut (2022)
Herbert Tilg, Timon Erik Adolph
A gut bacterium tackles atherosclerosis. Nature metabolism 4 (10) (2022)
Jiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, Lindsey Decommer, Leen Rymenans, Sebastian Proost, Javier Centelles Lodeiro, Martin Weger, Marlene Notdurfter, Christoph Leitner, Peter Santer, Gregorio Rungger, Johann Willeit, Peter Willeit, Raimund Pechlaner, Felix Grabherr, Stefan Kiechl, Herbert Tilg, Jeroen Raes
Long-term life history predicts current gut microbiome in a population-based cohort study. Nature aging 2 (10) (2022)
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut (2021)
Anna Mae Diehl, Nathalie J Farpour-Lambert, Liping Zhao, Herbert Tilg
Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease. Nature metabolism 1 (11) (2021)
Michael Dudek, Dominik Pfister, Sainitin Donakonda, Pamela Filpe, Annika Schneider, Melanie Laschinger, Daniel Hartmann, Norbert Hüser, Philippa Meiser, Felix Bayerl, Donato Inverso, Jennifer Wigger, Marcial Sebode, Rupert Öllinger, Roland Rad, Silke Hegenbarth, Martina Anton, Adrien Guillot, Andrew P Bowman, Danijela Heide, Florian Müller, Pierluigi Ramadori, Valentina Leone, Cristina Garcia-Caceres, Tim Gruber, Gabriel Seifert, Agnieszka M Kabat, Jan Philipp Mallm, Simon Reider, Maria Effenberger, Susanne Roth, Adrian T Billeter, Beat Müller-Stich, Edward J Pearce, Friedrich Koch-Nolte, Rafael Käser, Herbert Tilg, Robert Thimme, Tobias Boettler, Frank Tacke, Jean-François Dufour, Dirk Haller, Peter J Murray, Ron M A Heeren, Dietmar Zehn, Jan Philipp Böttcher, Mathias F Heikenwälder, Percy A Knolle
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. Nature 592 (7854) (2021)
Herbert Tilg, Timon Erik Adolph, Michael Dudek, Percy Knolle
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nature metabolism 3 (12) (2021)
Almina Jukic, Latifa Bakiri, Erwin F Wagner, Herbert Tilg, Timon E Adolph
Calprotectin: from biomarker to biological function. Gut 70 (10) (2021)
Maria Effenberger, Andreas Kronbichler, Erica L Bettac, Felix Grabherr, Christoph Grander, Timon Erik Adolph, Gert Mayer, Heinz Zoller, Paul Perco, Herbert Tilg
Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis. Journal of medical Internet research 23 (8) (2021)
Herbert Tilg, Maria Effenberger
From NAFLD to MAFLD: when pathophysiology succeeds. Nature reviews. Gastroenterology & hepatology 17 (7) (2020)
Herbert Tilg, Giovanni Targher
NAFLD-related mortality: simple hepatic steatosis is not as 'benign' as thought. Gut 70 (7) (2020)
Gianluca G Ianiro, Benjamin Harvey Mullish, Colleen R Kelly, Zain Kassam, Ed J Kuijper, William K K Wu, Tariq H Iqbal, Jessica R Allegretti, Stefano Bibbò, Harry Sokol, Faming Zhang, Monika Fischer, Samuel Paul Costello, Josbert J Keller, Luca Masucci, Joffrey van Prehn, Gianluca Quaranta, Mohammed Nabil Nabil Quraishi, Jonathan P Segal, Dina Kao, Reetta Satokari, Maurizio Sanguinetti, Herbert Tilg, Antonio Gasbarrini, Giovanni Cammarota
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 69 (9) (2020)
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut 70 (5) (2020)
Christoph Grander, Benedikt Schaefer, Julian Schwärzler, Felix Grabherr, Dennis M de Graaf, Barbara Enrich, Georg Oberhuber, Lisa Mayr, Moris Sangineto, Nikolai Jaschke, Timon E Adolph, Maria Effenberger, Alexander R Moschen, Charles A Dinarello, Heinz Zoller, Herbert Tilg
Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humans. Gut 70 (3) (2020)
William K K Wu, Herbert Tilg
COVID-19 and the gastrointestinal tract: more than meets the eye. Gut 69 (6) (2020)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69 (9) (2020)
Maria Effenberger, Felix Grabherr, Lisa Mayr, Julian Schwaerzler, Manfred Nairz, Markus Seifert, Richard Hilbe, Stefanie Seiwald, Sabine Scholl-Buergi, Gernot Fritsche, Rosa Bellmann-Weiler, Günter Weiss, Thomas Müller, Timon Erik Adolph, Herbert Tilg
Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 69 (8) (2020)
Herbert Tilg, Remy Burcelin, Valentina Tremaroli
Liver tissue microbiome in NAFLD: next step in understanding the gut-liver axis? Gut 69 (8) (2020)
Rui Wang, Ruqi Tang, Bo Li, Xiong Ma, Bernd Schnabl, Herbert Tilg
Gut microbiome, liver immunology, and liver diseases. Cellular & molecular immunology 18 (1) (2020)
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Valentina Giampaoli, Jörn M Schattenberg, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut 71 (1) (2020)
Herbert Tilg, Niv Zmora, Timon E Adolph, Eran Elinav
The intestinal microbiota fuelling metabolic inflammation. Nature reviews. Immunology 20 (1) (2019)
Timon E Adolph, Felix Grabherr, Lisa Mayr, Christoph Grander, Barbara Enrich, Alexander R Moschen, Herbert Tilg
Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression. Journal of obesity 2018 (2018)